RecruitingNot Applicable

Pilot Testing a Novel Remotely Delivered Intensive Outpatient Program for Individuals With OUD

United States20 participantsStarted 2023-11-17

Plain-language summary

This study aims to test a remotely delivered IOP program ("SmartIOP") for OUD patients who are hospitalized for serious injection-related infections. This will be a pilot trial to assess the feasibility of the IOP program and examine OUD-related outcomes following discharge from the hospital.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * English-speaking adults aged 18 and above * Any DSM-5 substance use disorder * Can identify at least 2 individuals who can act as points of contact following discharge from the hospital Exclusion Criteria: * Psychotic disorder, active suicidality, or homicidally * Condition likely to be terminal during the study period * Unable to perform consent due to impaired mental status

What they're measuring

Feasibility of the intervention program

Timeframe: Immediately Post Intervention

Trial details

NCT IDNCT05817825

SponsorBrigham and Women's Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-11

Contact for this trial

Joji Suzuki, MD

617-732-5752 jsuzuki2@bwh.harvard.edu

View on ClinicalTrials.gov More Opioid Use Disorder trials